OncLive SOSS

The Evolving Treatment Landscape of Renal Cell Carcinoma: Highlights from ESMO 2022 and Beyond - Episode 12

Systemic Therapy in the Treatment of Non-Clear Cell RCC: The Evolving Landscape

November 3, 2022

Thomas Powles, MD, Rana R. McKay, MD, Ulka Vaishampayan, MD, Eric Jonasch, MD, Benjamin Maughan, MD

Moving on to discuss the management of non–clear cell renal cell carcinoma, panelists consider cornerstone treatment options in this setting.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Overview on Clear Cell Renal Cell Carcinoma: Prevalence and Prognosis

EP. 2: What is the Role of Nephrectomy in Advanced Clear Cell RCC?

EP. 3: Selecting the Appropriate First-Line Therapy in Advanced Clear Cell RCC

EP. 4: Advanced Clear Cell RCC: Role of Site of Metastases in Selecting First-Line Therapy

EP. 5: Treating Patients with Clear Cell RCC with Brain Metastases or Sarcomatoid Disease

EP. 6: Advanced Clear Cell RCC: Quality of Life Data in First-Line Clinical Trials

EP. 7: First-Line Therapy in Advanced Clear Cell RCC: Novel Doublet Regimens

EP. 8: First-Line Therapy in Advanced Clear Cell RCC: Novel Triplet Regimens

EP. 9: Is There a Role for Adjuvant Therapy in Advanced Clear Cell RCC?

EP. 10: Treatment Options for Advanced Clear Cell RCC in the Second-Line and Beyond

EP. 11: Advanced Clear Cell RCC: Optimal Selection and Sequencing of Second-Line Therapy

EP. 12: Systemic Therapy in the Treatment of Non-Clear Cell RCC: The Evolving Landscape

EP. 13: Novel Treatment Strategies in Non-Clear Cell Renal Cell Carcinoma

EP. 14: Future Directions in the Management of Renal Cell Carcinoma

x